Studying pruritus in the 21st century.
Bergasa
Nora V
NV
D000469:Alkaline Phosphatase / Q000097:blood / Q000187:drug effects; D000982:Antipruritics / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood / Q000187:drug effects; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002756:Cholagogues and Choleretics / Q000008:administration & dosage; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D049674:History, 21st Century; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000188:drug therapy*; D011537:Pruritus / Q000097:blood / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D012709:Serum Albumin / Q000378:metabolism; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
D000982:Antipruritics; D015415:Biomarkers; D002756:Cholagogues and Choleretics; D004791:Enzyme Inhibitors; D012709:Serum Albumin; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D012293:Rifampin